MMedXYNews
Ask AIHomeVideos
MedXY AI/MedXY News/Section: news
news

Harnessing Genomics for Precision Prevention in Psychiatry: Opportunities and Challenges

MedXY Editorial TeamSep 2, 2026
Y học dự phòngPolygenic Scorespsychiatrygenomics

Highlight

  • Genomic testing is not currently recommended for universal screening in psychiatry due to modest predictive power and possible psychological harms.
  • Rare high-impact genetic variants have value in early clinical settings for diagnosis, prognosis, and personalized management.
  • Polygenic scores may aid in risk stratification within high-risk psychiatric populations when combined with non-genetic factors.
  • Pharmacogenomics and genomics-informed somatic risk assessment offer important opportunities for secondary and tertiary prevention in mental illness.

Background: Burden of Psychiatric Disorders and Need for Preventive Strategies

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Loading comments...

Most read

  1. 01Intimate Health

    Five Benefits for Women Continuing Sexual Activity After Menopause

  2. 02Intimate Health

    Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It

  3. 03Nursing & care

    How often should a couple have sex?

  4. 04Cardiology

    Precision Medicine for Long QT Syndrome Type 2: Lumacaftor Corrects Trafficking Defects and Shortens QT Interval

  5. 05General Surgery

    Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.

© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story